Complex role of protein phosphorylation in gene activation by hypoxia. Mammalian cells are able to sense decreased oxygen tension in their environment and turn-on the expression of specific hypoxia responsive genes. The best studied of these hypoxia regulated genes is the one that encodes for erythropoietin, the glycoproteiri hormone that regulates red cell production [1] . The response of the erythropoietin gene to hypoxia is mediated by an enhancer sequence located at the 3' flanking region of the gene [2] [3] [4] . A hypoxia inducible DNA-binding protein complex, termed HIF-1, regulates the transcriptional function of the erythropoietin enhancer [5]. Most interestingly, identical HIF-1 complexes also control the responses of other hypoxia regulated genes, in what appears to be a general mechanism of oxygen sensing and response [6, 7] . These other hypoxia regulated genes include vascular endothelial growth factor, glycolytic enzymes such as pyruvate kinase and aldolase A, glucose transporter I and endothelin, among others. All these genes are transcriptionally activated by hypoxia and also by transition metals such as cobalt (Co) and by iron chelators such as desferrioxamine (Dfx) [reviewed in 8].
tension in their environment and turn-on the expression of specific hypoxia responsive genes. The best studied of these hypoxia regulated genes is the one that encodes for erythropoietin, the glycoproteiri hormone that regulates red cell production [1] . The response of the erythropoietin gene to hypoxia is mediated by an enhancer sequence located at the 3' flanking region of the gene [2] [3] [4] . A hypoxia inducible DNA-binding protein complex, termed HIF-1, regulates the transcriptional function of the erythropoietin enhancer [5] . Most interestingly, identical HIF-1 complexes also control the responses of other hypoxia regulated genes, in what appears to be a general mechanism of oxygen sensing and response [6, 7] . These other hypoxia regulated genes include vascular endothelial growth factor, glycolytic enzymes such as pyruvate kinase and aldolase A, glucose transporter I and endothelin, among others. All these genes are transcriptionally activated by hypoxia and also by transition metals such as cobalt (Co) and by iron chelators such as desferrioxamine (Dfx) [reviewed in 8] .
Recently Wang and Semenza purified the protein components of the HIF-1 DNA-binding complex [9, 10] . Their biochemical purification revealed the presence of one subunit of about 120 kDa (HIF-la) and a second subunit, HIF-1f3 with polypeptides of 91, 93 and 94 kDa with a similar tryptic digestion composition. Cloning of the corresponding cDNAs showed that both subunits belong to a subfamily of basic-helix-loop-helix (b-HLH) transcription factors containing a PAS domain. HIF-Ia resulted to be a newly recognized member of the group while HIF-1/3 turn out to be the already described aryl hydrocarbon receptor nuclear translocator (ARNT) protein. These two proteins appear to form a heterodimer complex which then interact with the putative hypoxia-enhancer sequences. The mechanisms involved in the hypoxic induction of this DNA-binding complex are still not clear.
Regulation of HIF-1 complex formation
ARNT is also the partner of the aryl hydrocarbon receptor 
Protein phosphorylation and signal transduction
The mechanisms of oxygen sensing and signal transduction in the hypoxia response are still unknown. Protein phosphorylation is a widely used mechanism of signal transduction that has also been implicated in gene activation by low oxygen tension [14] [15] [16] .
To study the role of phosphorylation in the response to hypoxia we utilized several protein kinase inhibitors of different specificity. These studies were initially conducted in B-I cells, a permanently transfected Hep3B derived cell line expressing a Luciferase reporter eDNA under the control of a minimal erythropoietin promoter and the hypoxia responsive enhancer. These cells give a very sensitive and reproducible Luciferase response to hypoxia, cobalt and desferrioxamine. Results with the use of H-7, a rather general protein kiriase inhibitor, showed an almost complete inhibition of the Luciferase response to all three stimuli as depicted in Figure 2A . These initial results confirmed the role of protein phosphorylation in the hypoxia response. No effect on Luciferase expression was observed with the use of Wortmannin, a P1-3 kinase inhibitor (not shown), whereas Calphostin C, a protein kinase C inhibitor, was a strong inhibitor against Co and Dfx, but showed poor activity against hypoxia (Fig. 2B) . Genistein, a protein tyrosine kinase inhibitor was also a potent inhibitor against all three stimuli as shown in Figure 3A . The inhibition observed by these compounds on Luciferase activity was further evaluated by Northern blot analysis of the endogenous erythropoietin gene (Fig. 3B) , which confirmed the absolute inhibitory effect of Genistein (G) and the partial effect of Calphostin C (C). pathway has been traditionally associated with mitogenic responses, there is also recent evidence for its involvement in stress mediated responses [18] . As shown in Figure 4A , PD 098059 produced a dose dependent inhibition of the Luciferase response to Hx, Co and Dfx, with about 70% inhibition at 50 xM. To further study the mechanism of action of PD 098059, we evaluated its effects on HIF-1 complex formation. Nuclear extracts obtained from normal, 1-Ix, Co and Dfx treated cells were analyzed using gel shift assays with a radiolabeled HIF-1 binding site. Surprisingly, as shown in Figure 4B , PD 098059 had no effect on HIF-1 DNA binding activity induced by either stimulus. These results suggest first that there could be dissociation between DNA-binding activity and transcriptional activation, and second, it indicates that protein phosphorylation is likely involved in the trans-activating function of the HIF-1 complex. This lack of effect of protein phosphorylation on DNA-binding activity was further confirmed by the treatment of nuclear extracts with protein phosphatases, which showed no effect on DNA-binding activity (not shown). A similar dissociation between DNA-binding and transcriptional activation was recently described for the stress-induced phosphorylation and activation of the transcription factor CHOP, a member of the C/EBP family [191. Although significant advances have been made recently in our understanding of the mechanisms that regulate the responses to hypoxia, major questions still remain unanswered. Within these unknowns are the signal transduction pathways that determine the formation of the HIF-1 complex and the mechanisms used by this complex to increase transcriptional activity. Protein phosphoiylation is a common mechanism utilized by the cell for the rapid A. Cells were exposed to hypoxia (LI Fix), cobalt (+ Co) or desferrioxamine (K Dfx) for eight hours in the presence of increasing concentrations of H-7. Symbol • is normal. B. Cells were exposed, as above, to increasing concentrations of Calphostin C.
The transmission of these signal is usually mediated by a network of interacting protein kinases that governs a large number of cellular processes, including the transcriptional activation of genes. The studies presented here clearly confirm early reports of the involvement of protein phosphorylation events in the signal transduction of the hypoxia response. The pattern of phosphorylation is, however, rather complex. Inhibitors of protein kinase C were very effective in blocking the response to cobalt and desferrioxamine, but had little effect in the response to hypoxia. The tyrosine phosphorylation inhibitor Genistein was very effective against all stimuli and blocked both HIF-1 binding activity and gene expression. On the other hand, PD 098059, a highly specific inhibitor of the MAP pathway, inhibited gene expression, but not HIF-1 DNA-binding (Note added in proof). The results presented have just outlined the complexities of the signal tranduction pathways that culminate in gene activation in response to hypoxia. More studies will be needed to determine the mechanism by which low oxygen tension initiates these events, the nature of the protein kinases involved and the exact role of phosphorylation in the transactivation activity of the HIF-l complex.
Note added in proof
Although PD 09859 has been described as a specific inhibitor of MEK [171, preliminary results from our laboratory suggest that it could also affect the activity of P450 enzymes. The possible confounding effects of this finding on our results are currently being investigated. 
